The Pharmacist
DECEMBER 12, 2023
And it could save the community pharmacy sector anywhere between £15m and £150m, documents released last week suggested. The Department of Health and Social Care (DHSC) has predicted that proposed legislative changes to supervision could free up time for between 29% and 40% of pharmacists.
Pharmaceutical Technology
SEPTEMBER 7, 2022
The list includes providers of commercial solutions such as research and insights, market access and reimbursement, solutions to solve commercial challenges such as optimising launch performance and maintaining safe and effective usage, as well as technology solutions for activities such as remote patient monitoring, learning management, chat, and (..)
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
SEPTEMBER 8, 2022
The document contains detailed information on the suppliers and their product offerings, alongside contact details to aid your purchasing or hiring decision. Trending technologies in speciality pharmacies. . · Patient advocate support, and. Clinical interventions, and psychosocial and emotional assessment.
Pharmacy Joe
SEPTEMBER 6, 2023
In the first year after implementation over 2000 results were called to the pharmacy and about one-third resulted in the pharmacist ordering an antimicrobial.
Pharmacy Joe
SEPTEMBER 6, 2023
In the first year after implementation over 2000 results were called to the pharmacy and about one-third resulted in the pharmacist ordering an antimicrobial.
National Association of Boards of Pharmacy
JULY 19, 2024
For purposes of the exemption, a dispenser is considered a “small dispenser” if the corporate entity that owns the dispenser has a total of 25 or fewer full-time employees licensed as pharmacists or qualified as pharmacy technicians. Determine how many pharmacies are under the parent company.
National Association of Boards of Pharmacy
OCTOBER 23, 2024
The exemption applies to “any … eligible trading partners, which … have successfully completed or made documented efforts to complete data connections with their immediate trading partners.” FDA took the right approach balancing the advancement of DSCSA implementation with risk of potential impacts to the flow of medicine.
Expert insights. Personalized for you.
115 
Let's personalize your content